Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.
D000700:Analgesics; D000818:Animals; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D001341:Autonomic Nervous System / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D004232:Diuretics; D004285:Dogs; D004569:Electroencephalography; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects*; D011817:Rabbits; D051381:Rats
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D004232:Diuretics